New York Stock Exchange
-
Coupang Faces US Class-Action Lawsuit Over Data Breach; Judge Questions New York Jurisdiction
In a US class-action lawsuit concerning Coupang's massive personal data breach, jurisdiction has emerged as the key issue. Judge Ann Donnelly on Tuesday questioned why the case should be heard in New
-
NYSE owner ICE taps tZERO for tokenized securities push, takes stake in firm
The deal adds transfer-agent and settlement infrastructure to ICE's plans for an NYSE-affiliated market for tokenized stocks, tZERO said.
-
Texas Stock Exchange Lures Two ETFs From NYSE For Its First Primary Listings
The two small ETFs, Texas Capital Texas Index ETF (TXS) and Texas Capital Texas Oil Index ETF (OILT), are focused on the state’s economy and announced plans to transfer to the upstart marketplace.
-
Teva Pharmaceutical stock surged 12.3% last week, driven by better-than-expected Q2 sales and planned NYSE direct listing
Teva Pharmaceutical (NYSE: TEVA) stock rose approximately 12.3% last week. The surge was primarily attributed to the company's second-quarter report, which showed sales of $4.1 billion, surpassing ave
-
NYSE owner Intercontinental Exchange (ICE) to acquire MarketAxess for $6 billion, betting on rise of electronic bond trading
Intercontinental Exchange (ICE), owner of the New York Stock Exchange, is set to acquire MarketAxess in a $6 billion deal. The acquisition underscores ICE's strategic bet on the growing trend of elect
-
Texas Stock Exchange Debuts, Aims to Compete with NYSE and Nasdaq
The Texas Stock Exchange has rolled out trading for all tickers, stepping up its drive to win business from the New York Stock Exchange and Nasdaq.
-
Jersey Mike's Shares Fall 2% in NYSE Debut After Opening Below IPO Price
Jersey Mike's made its public market debut on the New York Stock Exchange (NYSE) under the ticker "JMKE". The sandwich chain priced its initial public offering (IPO) at $23 per share, but the stock op
-
Teva Pharmaceuticals CEO Discusses Positive Q2 Earnings and New NYSE Direct Listing
Teva Pharmaceuticals CEO Richard Francis discussed the company's positive second-quarter earnings and its new direct listing on the New York Stock Exchange (NYSE). He also addressed the impending impa
-
Coupang Faces US Class-Action Lawsuit Over Data Breach; Judge Questions New York Jurisdiction
In a US class-action lawsuit concerning Coupang's massive personal data breach, jurisdiction has emerged as the key issue. Judge Ann Donnelly on Tuesday questioned why the case should be heard in New
-
NYSE owner ICE taps tZERO for tokenized securities push, takes stake in firm
The deal adds transfer-agent and settlement infrastructure to ICE's plans for an NYSE-affiliated market for tokenized stocks, tZERO said.
-
Texas Stock Exchange Lures Two ETFs From NYSE For Its First Primary Listings
The two small ETFs, Texas Capital Texas Index ETF (TXS) and Texas Capital Texas Oil Index ETF (OILT), are focused on the state’s economy and announced plans to transfer to the upstart marketplace.
-
Teva Pharmaceutical stock surged 12.3% last week, driven by better-than-expected Q2 sales and planned NYSE direct listing
Teva Pharmaceutical (NYSE: TEVA) stock rose approximately 12.3% last week. The surge was primarily attributed to the company's second-quarter report, which showed sales of $4.1 billion, surpassing ave
-
NYSE owner Intercontinental Exchange (ICE) to acquire MarketAxess for $6 billion, betting on rise of electronic bond trading
Intercontinental Exchange (ICE), owner of the New York Stock Exchange, is set to acquire MarketAxess in a $6 billion deal. The acquisition underscores ICE's strategic bet on the growing trend of elect
-
Texas Stock Exchange Debuts, Aims to Compete with NYSE and Nasdaq
The Texas Stock Exchange has rolled out trading for all tickers, stepping up its drive to win business from the New York Stock Exchange and Nasdaq.
-
Jersey Mike's Shares Fall 2% in NYSE Debut After Opening Below IPO Price
Jersey Mike's made its public market debut on the New York Stock Exchange (NYSE) under the ticker "JMKE". The sandwich chain priced its initial public offering (IPO) at $23 per share, but the stock op
-
Teva Pharmaceuticals CEO Discusses Positive Q2 Earnings and New NYSE Direct Listing
Teva Pharmaceuticals CEO Richard Francis discussed the company's positive second-quarter earnings and its new direct listing on the New York Stock Exchange (NYSE). He also addressed the impending impa
- No data
New York Stock Exchange
24H Trending
-
1
PwC Adjusts India Operations, Forms Joint Venture with US Division to Counter AI Threat
-
2
ROKKIT FUEL ($ROKK) Token Status Analysis: Market Performance and Future Outlook Challenges
-
3
Elon Musk retweeted a post, expressing agreement with the view that "first achieve energy abundance, and everything else will naturally follow."
-
4
The Future of Terra Classic (LUNC): Impact of Binance's Burn Mechanism and CZ's Support
-
5
Where can TUSD be purchased? An analysis of TUSD's issuance and supply mechanism.
-
6
Global Mainstream Digital Currency Exchange Ranking Analysis: Regulatory Landscape in Mainland China and International Alternatives
-
7
Official App Download Guide and Security Tips for Mainstream Cryptocurrency Exchanges
-
8
BLOC Brick Cloud: An Analysis of the Current Status of a Once Highly Anticipated Blockchain Project and Its Token, BLOC
-
9
Hong Kong's 'shop kings' face bankruptcies as commercial property prices fall over 40% from 2018 peak, with no clear turnaround in sight
-
10
DARC Coin: A Multi-faceted Analysis of Konstellation Network DARC and the Status of DAR Open Network (D)
Markets Today
Recommended Reading







